Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

cipla malaysia sdn bhd - ritonavir; lopinavir -

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - lopinavir 100mg; ritonavir 25mg ((pharmacokinetic enhancer)) - film coated tablet - 100mg/25mg - active: lopinavir 100mg ritonavir 25mg ((pharmacokinetic enhancer)) excipient: colloidal silicon dioxide copovidone opadry yellow 85f32450 sodium stearyl fumarate sorbitan laurate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - lopinavir 200mg; ritonavir 50mg ((pharmacokinetic enhancer)) - film coated tablet - 200mg/50mg. - active: lopinavir 200mg ritonavir 50mg ((pharmacokinetic enhancer)) excipient: colloidal silicon dioxide   hyprolose hypromellose copovidone, k value 28 iron oxide yellow macrogol 3350 macrogol 400 polysorbate 80 purified talc sodium stearyl fumarate sorbitan laurate titanium dioxide - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - lopinavir 80 mg/ml; ritonavir 20 mg/ml ((pharmacokinetic enhancer)) - oral solution - active: lopinavir 80 mg/ml ritonavir 20 mg/ml ((pharmacokinetic enhancer)) excipient: acesulfame potassium ammonium glycyrrhizinate castor oil citric acid ethanol vanilla, natural and artifical 33869 cotton candy, artificial 30-92-0011 glycerol high fructose corn syrup levomenthol peppermint oil povidone propylene glycol purified water saccharin sodium sodium chloride sodium citrate dihydrate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - lopinavir 100 mg; ritonavir 25 mg - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infections.

European Union - English - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - lopinavir, ritonavir - hiv infections - antivirals for systemic use, protease inhibitors - kaletra is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children aged from 14 days and older.the choice of kaletra to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cipla medpro manufacturing (pty) ltd - pellet - see ingredients - each capsule contains lopinavir 40,0 mg ritonavir 10,0 mg

Kenya - English - Pharmacy and Poisons Board

abbvie (pty) ltd abbott place, 219 golf club terrace, constantia - lopinavir / ritonavir - tablet - lopinavir 100 mg / ritonavir 25 mg - antivirals for systemic use: protease inhibitors

Kenya - English - Pharmacy and Poisons Board

abbvie (pty) ltd abbott place 219 golf club terrace constantia - lopinavir / ritonavir - tablet - lopinavir 200 mg / ritonavir 50 mg - antivirals for systemic use: protease inhibitors

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - lopinavir; ritonavir -